Mary F. Davis

3.4k total citations
19 papers, 215 citations indexed

About

Mary F. Davis is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Mary F. Davis has authored 19 papers receiving a total of 215 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 3 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Mary F. Davis's work include Multiple Sclerosis Research Studies (6 papers), Mycobacterium research and diagnosis (3 papers) and Systemic Lupus Erythematosus Research (3 papers). Mary F. Davis is often cited by papers focused on Multiple Sclerosis Research Studies (6 papers), Mycobacterium research and diagnosis (3 papers) and Systemic Lupus Erythematosus Research (3 papers). Mary F. Davis collaborates with scholars based in United States and United Kingdom. Mary F. Davis's co-authors include Jonathan L. Haines, Farren Briggs, William S. Bush, Joshua C. Denny, Thomas M. Vernon, Subramaniam Sriram, Donald C. Iverson, Karen Rosenberg, Douglas Gunzler and Daniel Ontaneda and has published in prestigious journals such as PLoS ONE, Neurology and International Journal of Environmental Research and Public Health.

In The Last Decade

Mary F. Davis

18 papers receiving 204 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary F. Davis United States	8	82	40	30	29	25	19	215
Claude L. Cowan United States	11	34 0.4×	39 1.0×	11 0.4×	20 0.7×	63 2.5×	20	595
Gobinda Chatterjee India	10	76 0.9×	44 1.1×	20 0.7×	4 0.1×	69 2.8×	54	327
Anna Kernder Germany	7	51 0.6×	26 0.7×	158 5.3×	21 0.7×	14 0.6×	20	269
Á. Zulaica Spain	11	27 0.3×	31 0.8×	15 0.5×	5 0.2×	60 2.4×	31	244
Trudy L. Campbell Canada	5	313 3.8×	16 0.4×	59 2.0×	9 0.3×	35 1.4×	7	358
Chih‐Tsung Hung Taiwan	9	40 0.5×	18 0.5×	50 1.7×	5 0.2×	35 1.4×	33	235
Rupendra T. Shrestha United States	10	41 0.5×	25 0.6×	7 0.2×	5 0.2×	23 0.9×	20	328
Verónica Rivas‐Alonso Mexico	9	151 1.8×	22 0.6×	35 1.2×	4 0.1×	18 0.7×	29	290
Benjamin K. Young United States	13	26 0.3×	90 2.3×	6 0.2×	30 1.0×	53 2.1×	66	435
Esther Burden‐Teh United Kingdom	11	17 0.2×	44 1.1×	39 1.3×	12 0.4×	35 1.4×	23	387

Countries citing papers authored by Mary F. Davis

Since Specialization

Citations

This map shows the geographic impact of Mary F. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary F. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary F. Davis more than expected).

Fields of papers citing papers by Mary F. Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary F. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary F. Davis. The network helps show where Mary F. Davis may publish in the future.

Co-authorship network of co-authors of Mary F. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Mary F. Davis. A scholar is included among the top collaborators of Mary F. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary F. Davis. Mary F. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Bates, B., et al.. (2025). Intersection of rare pathogenic variants from TCGA in the All of Us Research Program v6. Human Genetics and Genomics Advances. 6(2). 100405–100405. 1 indexed citations

Grose, Julianne H., et al.. (2024). Genomic Analyses of Major SARS-CoV-2 Variants Predicting Multiple Regions of Pathogenic and Transmissive Importance. Viruses. 16(2). 276–276. 2 indexed citations

Davis, Mary F., et al.. (2023). Influence of Admixture on Phenotypes. Current Protocols. 3(12). e953–e953.

Davis, Mary F., et al.. (2021). A higher burden of multiple sclerosis genetic risk confers an earlier onset. Multiple Sclerosis Journal. 28(8). 1189–1197. 11 indexed citations

Johnson, Deborah, et al.. (2021). Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis. PLoS ONE. 16(1). e0243150–e0243150. 13 indexed citations

Briggs, Farren, et al.. (2021). The Impact of Multiple Sclerosis Disease Status and Subtype on Hematological Profile. International Journal of Environmental Research and Public Health. 18(6). 3318–3318. 7 indexed citations

Briggs, Farren, et al.. (2020). Depression in multiple sclerosis patients associated with risk variant near NEGR1. Multiple Sclerosis and Related Disorders. 46. 102537–102537. 5 indexed citations

Wang, Frances, Mary F. Davis, & Farren Briggs. (2020). Predicting self-reported depression after the onset of multiple sclerosis using genetic and non-genetic factors. Multiple Sclerosis Journal. 27(4). 603–612. 9 indexed citations

Briggs, Farren & Mary F. Davis. (2019). Multiple sclerosis genetic risk burden confers earlier onset. (S49.001). Neurology. 92(15_supplement). 1 indexed citations

10.

Briggs, Farren, et al.. (2018). Multiple sclerosis risk factors contribute to onset heterogeneity. Multiple Sclerosis and Related Disorders. 28. 11–16. 42 indexed citations

11.

Davis, Mary F., et al.. (2016). Uric Acid Levels in Relation to Progression of Multiple Sclerosis. ScholarsArchive (Brigham Young University). 1 indexed citations

12.

Pallister, Kyler B., Tyler K. Nygaard, Bin Liu, et al.. (2015). Bovine CCL28 Mediates Chemotaxis via CCR10 and Demonstrates Direct Antimicrobial Activity against Mastitis Causing Bacteria. PLoS ONE. 10(9). e0138084–e0138084. 8 indexed citations

13.

Davis, Mary F. & Jonathan L. Haines. (2014). The intelligent use and clinical benefits of electronic medical records in multiple sclerosis. Expert Review of Clinical Immunology. 11(2). 205–211. 6 indexed citations

14.

Dementieva, Yulia, Donald A. Primerano, Liping Wei, et al.. (2014). Identification of genes contributing to cardiovascular disease in overweight and obese individuals from West Virginia.. PubMed. 108(1). 23–6, 28. 2 indexed citations

15.

Davis, Mary F., Anna Cummings, Lan Jiang, et al.. (2013). Parkinson disease loci in the mid-western Amish. Human Genetics. 132(11). 1213–1221. 14 indexed citations

16.

Cummings, Anna, Mary F. Davis, William K. Scott, et al.. (2013). Evaluating Power and Type 1 Error in Large Pedigree Analyses of Binary Traits. PLoS ONE. 8(5). e62615–e62615. 6 indexed citations

17.

Davis, Mary F., Subramaniam Sriram, William S. Bush, Joshua C. Denny, & Jonathan L. Haines. (2013). Automated extraction of clinical traits of multiple sclerosis in electronic medical records. Journal of the American Medical Informatics Association. 20(e2). e334–e340. 41 indexed citations

18.

Clark, Lauren, et al.. (1996). Adolescent Health Promotion in a Low-Income, Urban Environment. Family & Community Health. 19(1). 1–13. 5 indexed citations

19.

Davis, Mary F., et al.. (1985). Worksite health promotion in Colorado.. PubMed. 99(6). 538–43. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact